20261873: Novartis AG; Myricx Pharma Limited

Дата публикации: 05-08-2026 17:32:40

20261873: Novartis AG; Myricx Pharma Limited
Date

August 4, 2026

bjames@ftc.gov
August 5, 2026 | 1:32PM
Transaction Number

20261873

Acquiring Party

Novartis AG

Acquired Party

Myricx Pharma Limited

Granting Status

Granted

Acquired Entities

Myricx Pharma Limited

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	20261890: Vertex Pharmaceuticals Incorporated; Crinetics Pharmaceuticals, Inc.	0	5.9	14-08-2026
2	20261875: ON Semiconductor Corporation; Synaptics Incorporated	0	6.07	14-08-2026
3	20261870: Accenture plc; Bain Capital Europe Fund V SCSp	0	5.9	05-08-2026
4	20261857: CVC Capital Partners IX (A) L.P.; DK Holdco, LLC	0	6.07	05-08-2026
5	20261904: Invidia Bright Topco LP; Massimo Musa	0	6.07	14-08-2026
6	20261925: Merit France SAS; FedEx Corporation	0	6.07	14-08-2026
7	20261901: Bridgepoint Group plc; Albert Rabil III	0	6.07	14-08-2026
8	20261888: Solstice Advanced Materials Inc.; Element Solutions Inc	0	5.73	14-08-2026
9	20261902: Bridgepoint Group plc; Kayne Anderson Capital Advisors, L.P.	0	5.9	14-08-2026
10	FTC Takes Action to Protect Americans from Higher Drug Costs in Aurobindo, Lannett Deal	0	5.3	18-06-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 6.07. Источник: www.ftc.gov.